NCT03844984View on ClinicalTrials.gov

Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

September 20, 2019

Study Completion Date

September 20, 2019

Conditions
Septic Shock
Interventions
DRUG

ketamine full dose

This group will receive induction of anesthesia using Ketamine 1 mg/Kg.

DRUG

Midazolam

This group will receive midazolam 0.05 mg/Kg

DRUG

Normal saline

This group will receive normal saline 10 mL

DRUG

ketamine half dose

This group will receive induction of anesthesia using Ketamine 0.5 mg/Kg.

DRUG

Lidocaine

This group will receive lidocaince 1 mg/Kg diluted in 10 mL normal saline.

Trial Locations (1)

11432

Ahmed Mohamed Hasanin, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03844984 - Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients | Biotech Hunter | Biotech Hunter